Foley Welcomes Joseph McClendon III for a Conversation on Empowering our Diverse Attorneys
October 21, 2020
This month, the firm’s Black Attorneys Affinity Group and Hispanic Attorneys Affinity Group welcomed Joseph McClendon III for a conversation on “Empowering our Diverse Attorneys.” Joseph is a Doctor of Neuropsychology and a sought after Ultimate Performance Specialists. For the last several decades, Joseph has been passionate about empowering diverse communities to overcome societal roadblocks to live a life of their dreams. In 1997, he and Tony Robbins authored the book, Unlimited Power: A Black Choice. During his discussion with affinity group members, Joseph provided actionable advice for addressing intergenerational trauma, moving forward in difficult circumstances, and tapping in to one’s best self. Many thanks to Hispanic Affinity Group Co-Chair Jessica Gonzalez for her work in bringing this important conversation to the firm.
Disclaimer
This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.
Author(s)
Related Insights
April 14, 2026
Health Care Law Today
FDA Clarifies Policies for Pharmacy Compounders of GLP-1 Products
On April 1, 2026,the U.S. Food & Drug Administration (FDA) issued a statement clarifying its compliance policy on the conditions that must be met for compounded drugs to qualify for the exemptions under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
April 14, 2026
Foley Career Perspectives
Trust Your Instincts: Susan Pravda on Leadership, Relationships, and Resilience
Foley partner Susan Pravda is a business lawyer focused on mergers and acquisitions, venture capital, initial public offerings, and related securities transactions and is head of Foley’s Health Care & Life Sciences Sector. She also serves as the firm’s chief strategic talent acquisition partner.
April 14, 2026
Foley Viewpoints
Private Equity in Q1 2026: Resilient Activity, Constrained Capital Environment
PE deal activity remained robust in Q1 despite being down QoQ, with 5,100 transactions valued at $481.6 billion. Exit activity was also down but still healthy, with 975 transactions valued at $306.7 billion. Fundraising activity remained soft, with only $86 billion raised in Q1.